Crossmark

Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice

Published Online: 2023-01-10

Published Print: 2023-06

Authors

Xu, Hao-wen

Li, Wei-feng

Hong, Shan-shan

Shao, Jing-jing

Chen, Jia-hao

Chattipakorn, Nipon

Wu, Di

Luo, Wu

Liang, Guang
License Information

Text and Data Mining valid from 2023-01-10

Version of Record valid from 2023-01-10
More Information

Article History

Received: 25 August 2022

Accepted: 6 December 2022

First Online: 10 January 2023

Competing interests

: The authors declare no competing interests.

Document is current